FSCM
ABBV icon

Front Street Capital Management’s AbbVie ABBV Stock Holding History

Front Street Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-709
Closed -$110K – 71
2023
Q4 		$110K Buy
709
+34
+5% +$4.96K 0.02% 88
2023
Q3 		$101K Buy
+675
New +$99.1K 0.02% 87

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Front Street Capital Management's ABBV Position: Q1 2024 in Review

Front Street Capital Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 709 shares — an estimated $110K sold.

Front Street Capital Management first reported a position in ABBV in Q3 2023 and held it in 2 quarters. The position peaked at $110K in Q4 2023. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Front Street Capital Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Front Street Capital Management sold 709 AbbVie shares in Q1 2024, an estimated $110K.
  • Front Street Capital Management first reported a position in AbbVie in Q3 2023 and held it in 2 quarters.
  • Front Street Capital Management's AbbVie position peaked at $110K in Q4 2023.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Front Street Capital Management's 13F filing for Q1 2024, filed 14 May 2024.